Document is current
Any future updates will be listed below
-
Authors
Bogdanow, Boris https://orcid.org/0000-0002-9634-7353
Ruwolt, Max
Ruta, Julia https://orcid.org/0009-0007-0524-6885
Mühlberg, Lars https://orcid.org/0009-0008-8046-007X
Wang, Cong
Zeng, Wen-feng
Elofsson, Arne https://orcid.org/0000-0002-7115-9751
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (BO 5917/1-1, LI 3260/6-1)
EC | ERC | HORIZON EUROPE European Research Council (ERC-STG No. 949184)
Leibniz Publik (K284/2019)
Vetenskapsrådet (Berzelius-2021-29, SNIC 2022/5-282)
- License Information
-
More Information
Article History
Received: 27 May 2024
Revised: 20 November 2024
Accepted: 21 November 2024
First Online: 9 December 2024
Disclosure and competing interests statement
: FL is a shareholder and advisory board member of Absea Biotechnology Ltd. and VantAI. The remaining authors declare no competing interests.
